All In MedTech

FDA Clearance Tracker · P120006-S031

Alto Abdominal Stent Graft System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 13, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 13, 2020

Approved

Time to decision

366 days

Received Mar 13, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P120006-S031
Device name
Alto Abdominal Stent Graft System
Applicant location
Santa Rosa, CA
Received
Mar 13, 2019
Decided
Mar 13, 2020
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P120006

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval for the Alto Abdominal Stent Graft System. The device is indicated for treatment of patients with infrarenal abdominal aortic aneurysms having the vascular morphology suitable for endovascular repair with the device, which includes the following:1) Adequate iliac/femoral access compatible with vascular access techniques (femoral cutdown or percutaneous), devices, and/or accessories;2) A proximal aortic landing zone for the sealing ring 7mm below the inferior renal artery; 3) An aortic sealing zone comprised of healthy aorta defined as; a. Lack of significant thrombus > 8 mm in thickness; at any point along the aortic circumference at the level of 7mm below the inferior renal artery; b. Lack of significant calcification at the level of 7mm below the inferior renal artery; c. Conicity < 10% as measured from the inferior renal artery to the aorta 7mm below the inferior renal artery; d. An inner wall diameter of no less than 16 mm and no greater than 30 mm at 7 mm below the inferior renal artery; and e. An aortic angle of <= 60 degrees. 4) A distal iliac landing zone: a. With a length of at least 10 mm; and b. With an inner wall diameter of no less than 8 mm and no greater than 25 mm.

Source documents

Other decisions for Endologix, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.